# Incyte Corp: financial statements, quarterly

INCY · Nasdaq · CIK 879169 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/incy.md) · [Financials](/companies/incy/financials.md) · [Filings](/companies/incy/filings.md) · [Insiders](/companies/incy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/incy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,013 d](/filings/0000879169-26-000010.md) | [881](/filings/0000879169-25-000056.md) | [1,044](/filings/0000879169-25-000103.md) | [1,138](/filings/0000879169-25-000118.md) | [1,179 d](/filings/0000879169-26-000010.md) | [1,053](/filings/0000879169-26-000026.md) | [1,216](/filings/0000879169-26-000056.md) | [1,366](/filings/0000879169-26-000066.md) | [1,507 d](/filings/0000879169-26-000010.md) | [1,273](/filings/0000879169-26-000026.md) | [1,674](/filings/0000879169-26-000056.md) | [1,557](/filings/0000879169-26-000066.md) |
| Cost of revenue | $m | [69.8 d](/filings/0000879169-26-000010.md) | [61.0](/filings/0000879169-25-000056.md) | [76.6](/filings/0000879169-25-000103.md) | [86.0](/filings/0000879169-25-000118.md) | [88.5 d](/filings/0000879169-26-000010.md) | [73.2](/filings/0000879169-26-000026.md) | [78.8](/filings/0000879169-26-000056.md) | [99.0](/filings/0000879169-26-000066.md) | [121 d](/filings/0000879169-26-000010.md) | [105](/filings/0000879169-26-000026.md) | [105](/filings/0000879169-26-000056.md) | [109](/filings/0000879169-26-000066.md) |
| Research and development | $m | [444 d](/filings/0000879169-26-000010.md) | [429](/filings/0000879169-25-000056.md) | [1,138](/filings/0000879169-25-000103.md) | [573](/filings/0000879169-25-000118.md) | [466 d](/filings/0000879169-26-000010.md) | [437](/filings/0000879169-26-000026.md) | [495](/filings/0000879169-26-000056.md) | [507](/filings/0000879169-26-000066.md) | [611 d](/filings/0000879169-26-000010.md) | [516](/filings/0000879169-26-000026.md) | [517](/filings/0000879169-26-000056.md) | [1,792](/filings/0000879169-26-000066.md) |
| Selling, general and administrative | $m | [288 d](/filings/0000879169-26-000010.md) | [300](/filings/0000879169-25-000056.md) | [306](/filings/0000879169-25-000103.md) | [309](/filings/0000879169-25-000118.md) | [327 d](/filings/0000879169-26-000010.md) | [326](/filings/0000879169-26-000026.md) | [331](/filings/0000879169-26-000056.md) | [329](/filings/0000879169-26-000066.md) | [390 d](/filings/0000879169-26-000010.md) | [328](/filings/0000879169-26-000026.md) | [352](/filings/0000879169-26-000056.md) | [364](/filings/0000879169-26-000066.md) |
| Operating income | $m | [187 d](/filings/0000879169-26-000010.md) | [91.9](/filings/0000879169-25-000056.md) | [(478)](/filings/0000879169-25-000103.md) | [146](/filings/0000879169-25-000118.md) | [302 d](/filings/0000879169-26-000010.md) | [205](/filings/0000879169-26-000026.md) | [530](/filings/0000879169-26-000056.md) | [444](/filings/0000879169-26-000066.md) | [336 d](/filings/0000879169-26-000010.md) | [301](/filings/0000879169-26-000026.md) | [698](/filings/0000879169-26-000056.md) | [(708)](/filings/0000879169-26-000066.md) |
| Interest expense | $m | [0.8 d](/filings/0000879169-24-000045.md) | [0.4](/filings/0000879169-24-000077.md) | [0.7](/filings/0000879169-25-000103.md) | [0.8](/filings/0000879169-25-000118.md) | [0.4 d](/filings/0000879169-26-000010.md) | [0.7](/filings/0000879169-26-000026.md) | [0.6](/filings/0000879169-26-000056.md) | [0.6](/filings/0000879169-26-000066.md) | [0.6 d](/filings/0000879169-26-000010.md) | [0.6](/filings/0000879169-26-000026.md) | [0.6](/filings/0000879169-26-000056.md) | [0.6](/filings/0000879169-26-000066.md) |
| Income tax | $m | [69.9 d](/filings/0000879169-26-000010.md) | [66.6](/filings/0000879169-25-000056.md) | [54.8](/filings/0000879169-25-000103.md) | [50.1](/filings/0000879169-25-000118.md) | [113 d](/filings/0000879169-26-000010.md) | [76.0](/filings/0000879169-26-000026.md) | [153](/filings/0000879169-26-000056.md) | [58.1](/filings/0000879169-26-000066.md) | [90.7 d](/filings/0000879169-26-000010.md) | [40.3](/filings/0000879169-26-000026.md) | [166](/filings/0000879169-26-000056.md) | [96.0](/filings/0000879169-26-000066.md) |
| Net income | $m | [201 d](/filings/0000879169-26-000010.md) | [170](/filings/0000879169-25-000118.md) | [(445)](/filings/0000879169-25-000118.md) | [106](/filings/0000879169-25-000118.md) | [201 d](/filings/0000879169-26-000010.md) | [158](/filings/0000879169-26-000066.md) | [405](/filings/0000879169-26-000066.md) | [424](/filings/0000879169-26-000066.md) | [299 d](/filings/0000879169-26-000010.md) | [303](/filings/0000879169-26-000066.md) | [586](/filings/0000879169-26-000066.md) | [(785)](/filings/0000879169-26-000066.md) |
| Diluted EPS | $ per share | not reported | [0.75](/filings/0000879169-25-000056.md) | [(2.04)](/filings/0000879169-25-000103.md) | [0.54](/filings/0000879169-25-000118.md) | not reported | [0.80](/filings/0000879169-26-000026.md) | [2.04](/filings/0000879169-26-000056.md) | [2.11](/filings/0000879169-26-000066.md) | not reported | [1.47](/filings/0000879169-26-000026.md) | [2.81](/filings/0000879169-26-000056.md) | [(3.86)](/filings/0000879169-26-000066.md) |
| Basic EPS | $ per share | not reported | [0.76](/filings/0000879169-25-000056.md) | [(2.04)](/filings/0000879169-25-000103.md) | [0.55](/filings/0000879169-25-000118.md) | not reported | [0.82](/filings/0000879169-26-000026.md) | [2.09](/filings/0000879169-26-000056.md) | [2.17](/filings/0000879169-26-000066.md) | not reported | [1.52](/filings/0000879169-26-000026.md) | [2.92](/filings/0000879169-26-000056.md) | [(3.86)](/filings/0000879169-26-000066.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3,213](/filings/0001628280-25-004633.md) | [3,346](/filings/0000879169-24-000077.md) | [987](/filings/0000879169-24-000149.md) | [1,304](/filings/0000879169-24-000172.md) | [1,688](/filings/0000879169-26-000010.md) | [1,942](/filings/0000879169-25-000056.md) | [1,955](/filings/0000879169-25-000103.md) | [2,455](/filings/0000879169-25-000118.md) | [3,098](/filings/0000879169-26-000066.md) | [3,461](/filings/0000879169-26-000026.md) | [3,982](/filings/0000879169-26-000056.md) | [3,276](/filings/0000879169-26-000066.md) |
| Current assets | $m | [4,645](/filings/0001628280-25-004633.md) | [4,849](/filings/0000879169-24-000077.md) | [2,567](/filings/0000879169-24-000149.md) | [2,809](/filings/0000879169-24-000172.md) | [3,239](/filings/0000879169-26-000010.md) | [3,507](/filings/0000879169-25-000056.md) | [3,644](/filings/0000879169-25-000103.md) | [4,278](/filings/0000879169-25-000118.md) | [5,024](/filings/0000879169-26-000066.md) | [5,484](/filings/0000879169-26-000026.md) | [6,027](/filings/0000879169-26-000056.md) | [5,521](/filings/0000879169-26-000066.md) |
| Total assets | $m | [6,782](/filings/0001628280-25-004633.md) | [7,136](/filings/0000879169-24-000077.md) | [4,662](/filings/0000879169-24-000149.md) | [5,012](/filings/0000879169-24-000172.md) | [5,444](/filings/0000879169-26-000010.md) | [5,749](/filings/0000879169-25-000056.md) | [5,821](/filings/0000879169-25-000103.md) | [6,330](/filings/0000879169-25-000118.md) | [6,958](/filings/0000879169-26-000066.md) | [7,339](/filings/0000879169-26-000026.md) | [7,873](/filings/0000879169-26-000056.md) | [7,287](/filings/0000879169-26-000066.md) |
| Current liabilities | $m | [1,240](/filings/0001628280-25-004633.md) | [1,396](/filings/0000879169-24-000077.md) | [1,337](/filings/0000879169-24-000149.md) | [1,502](/filings/0000879169-24-000172.md) | [1,642](/filings/0000879169-26-000010.md) | [1,720](/filings/0000879169-25-000056.md) | [1,279](/filings/0000879169-25-000103.md) | [1,339](/filings/0000879169-25-000118.md) | [1,515](/filings/0000879169-26-000066.md) | [1,490](/filings/0000879169-26-000026.md) | [1,312](/filings/0000879169-26-000056.md) | [1,438](/filings/0000879169-26-000066.md) |
| Total liabilities | $m | [1,592](/filings/0001628280-25-004633.md) | [1,741](/filings/0000879169-24-000077.md) | [1,665](/filings/0000879169-24-000149.md) | [1,841](/filings/0000879169-24-000172.md) | [1,997](/filings/0000879169-26-000010.md) | [2,082](/filings/0000879169-25-000056.md) | [1,650](/filings/0000879169-25-000103.md) | [1,679](/filings/0000879169-25-000118.md) | [1,790](/filings/0000879169-26-000066.md) | [1,716](/filings/0000879169-26-000026.md) | [1,528](/filings/0000879169-26-000056.md) | [1,644](/filings/0000879169-26-000066.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [5,190](/filings/0000879169-26-000010.md) | [5,394](/filings/0000879169-25-000118.md) | [2,997](/filings/0000879169-25-000118.md) | [3,171](/filings/0000879169-25-000118.md) | [3,448](/filings/0000879169-26-000066.md) | [3,668](/filings/0000879169-26-000066.md) | [4,171](/filings/0000879169-26-000066.md) | [4,651](/filings/0000879169-26-000066.md) | [5,167](/filings/0000879169-26-000066.md) | [5,623](/filings/0000879169-26-000066.md) | [6,344](/filings/0000879169-26-000066.md) | [5,643](/filings/0000879169-26-000066.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [148 d](/filings/0000879169-26-000010.md) | [219](/filings/0000879169-25-000056.md) | [(576) d](/filings/0000879169-25-000103.md) | [311 d](/filings/0000879169-25-000118.md) | [381 d](/filings/0000879169-26-000010.md) | [266](/filings/0000879169-26-000026.md) | [44.7 d](/filings/0000879169-26-000056.md) | [559 d](/filings/0000879169-26-000066.md) | [543 d](/filings/0000879169-26-000010.md) | [369](/filings/0000879169-26-000026.md) | [508 d](/filings/0000879169-26-000056.md) | [(675) d](/filings/0000879169-26-000066.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0000879169-26-000010.md) | not reported | not reported | [0.1 d](/filings/0000879169-25-000118.md) | [0.0 d](/filings/0000879169-26-000010.md) | not reported | not reported | [0.0 d](/filings/0000879169-25-000118.md) | [0.0 d](/filings/0000879169-26-000010.md) | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [226](/filings/0000879169-24-000077.md) | [226](/filings/0000879169-24-000149.md) | [226](/filings/0000879169-24-000172.md) | [227](/filings/0000879169-25-000056.md) | [218](/filings/0000879169-25-000103.md) | [196](/filings/0000879169-25-000118.md) | [198](/filings/0000879169-26-000026.md) | [199](/filings/0000879169-26-000056.md) | [201](/filings/0000879169-26-000066.md) | [207](/filings/0000879169-26-000026.md) | [208](/filings/0000879169-26-000056.md) | [203](/filings/0000879169-26-000066.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 203,832,492 at 2026-10-22, from the cover of the [10-Q filed 2026-10-29](/filings/0000879169-26-000066.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 16:38 ET. No prices; not investment advice.